Bo Mølholm Hansen

Dr. Bo Mølholm Hansen


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ADAnne Louise Damgaard
Anne Louise Damgaard
BHBo Mølholm Hansen
Bo Mølholm Hansen
RMRené Mathiasen
René Mathiasen
FBFrederik Buchvald
Frederik Buchvald
TLTheis Lange
Theis Lange
GGGorm Greisen
Gorm Greisen
Preterm birth is associated with increased risk of asthma-like symptoms and purchase of prescription asthma medication in childhood. We investigated whether this association persists into adulthood and whether it is affected by accounting for neonatal respiratory morbidity (acute respiratory disease and bronchopulmonary dysplasia). A national cohort of all infants born in Denmark in the period 1980–2009 was included in this register study. Data on purchase of asthma medication (combination of inhaled β-2 agonists and other drugs for obstructive airway disease) in 2010–2011 were obtained from the Danish National Prescription Registry. Associations between gestational age (GA), neonatal respiratory morbidity and a cross-sectional evaluation of asthma medication purchase were explored by multivariate logistic regressions. A full dataset was obtained on 1,790,241 individuals, 84.6% of all infants born in the period. Odds-ratios (95% CI) for the association between GA and purchase of asthma medication during infancy were: 3.86 (2.46–6.04) in GA 23–27 weeks, 2.37 (1.84–3.04) in GA 28–31 weeks and 1.59 (1.43–1.77) in GA 32–36 weeks compared to term infants with GA 37–42 weeks. Associations weakened in older age groups and became insignificant in young adults born extremely and very preterm with odds-ratios: 1.41 (0.63–3.19) and 1.15 (0.83–1.60) in GA 23–27 and 28–31 respectively. When adjusting for neonatal respiratory morbidity, the associations weakened but persisted both in childhood and adolescence. There was a strong dose-response association between gestational age and the purchase of prescription asthma medication in infancy and childhood. This association weakened during adolescence and was mostly non-significant in young adulthood. The increased risk of prescription asthma medication purchase in ex-preterm children could only partly be explained by neonatal respiratory morbidity.

1 February 2016 in Pediatrics
Verified
Journal Article
Closed access
PDF file
CHCarolina Hvelplund
Carolina Hvelplund
BHBo Mølholm Hansen
Bo Mølholm Hansen
SKSusanne Vinkel Koch
Susanne Vinkel Koch
MAMikael Andersson
Mikael Andersson
ASAnne Mette Skovgaard
Anne Mette Skovgaard
OBJECTIVE: To describe the incidence, age at diagnosis, and associations between perinatal risk factors of feeding and eating disorders (FED) diagnosed at hospital in children aged 0 to 3 years. METHODS: A nationwide cohort of 901 227 children was followed until 48 months of age in the national registers from 1997 to 2010. Multivariable Cox proportional hazards regression was used to estimate hazard ratios (HRs) for FED diagnosis according to the International Classification of Diseases and associations with perinatal risk factors. RESULTS: A total of 1365 children (53% girls) were diagnosed with FED at hospital, corresponding to a cumulative incidence of 1.6 per 1000 live births. High risk of FED was seen in children born before gestational week 28 (HR, 3.52; 95% confidence interval [CI], 2.15–5.78). HRs were 3.74 for children small for gestational age ≤3 SD (95% CI, 2.71–5.17) and 4.71 in those with congenital malformations (95% CI, 3.86–5.74). Increased risk of FED was associated with female gender (HR, 1.2; 95% CI, 1.08–1.34), maternal smoking in pregnancy (HR, 1.24; 95% CI, 1.08–1.42), immigrant status (HR, 2.24; 95% CI, 1.92–2.61), and being the firstborn (HR, 1.33; 95% CI, 1.19–1.50). CONCLUSIONS: FED in referred children aged 0 to 3 years are associated with perinatal adversities, female gender, maternal smoking in pregnancy, being firstborn, and having immigrant parents. The results suggest complex causal mechanisms of FED and underscore the need for a multidisciplinary approach in the clinical management of young children with persistent problems of feeding, eating, and weight faltering.

29 October 2014 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
PVPernille Kure Vandborg
Pernille Kure Vandborg
BHBo Mølholm Hansen
Bo Mølholm Hansen
GGGorm Greisen
Gorm Greisen
RMRené Mathiasen
René Mathiasen
FKFrederikke Kasper
Frederikke Kasper
FEFinn Ebbesen
Finn Ebbesen
Aim: To investigate whether infants with neonatal hyperbilirubinaemia but without intermediate or advanced bilirubin encephalopathy develop long‐term sequelae, with impairment of motor development, executive function, or hearing.Method: This nested double‐cohort study included 167 exposed children (107 males, 60 females) born in Denmark 2000 to 2005 at gestational age ≥35 weeks with a total serum bilirubin ≥450 μmol/L (26.3mg/dL) and 163 age‐, sex‐, and gestational age‐matched unexposed children (103 males, 60 females). The children were examined at a mean age of 7.7 years (SD 1.7y) using the Movement Assessment Battery for Children–Second Edition (MABC‐2), pure tone audiometry, and the Behavioural Regulation Inventory of Executive Function (BRIEF) questionnaire.Results: The follow‐up rate was 70% of the eligible infants in the exposed group and 45% in the unexposed group. Mean difference was −0.2 (95% confidence interval [CI] −1.1 to 0.8) in adjusted standard score for MABC‐2 and 0.3 (95% CI −2.9 to 3.5) in adjusted BRIEF executive composite standard score. No children had significant hearing impairment or a diagnosis of cerebral palsy, attention‐deficit–hyperactive disorder, or autism spectrum disorder recorded in national registries.Interpretation: No evidence was found of an increased risk of deficits in motor development, executive function, or hearing in children with extreme hyperbilirubinaemia who did not have intermediate or advanced bilirubin encephalopathy.

1 July 2012 in Pediatrics
Verified
Journal Article
Closed access
PDF file
PVPernille Kure Vandborg
Pernille Kure Vandborg
BHBo Mølholm Hansen
Bo Mølholm Hansen
GGGorm Greisen
Gorm Greisen
MJMia Jepsen
Mia Jepsen
FEFinn Ebbesen
Finn Ebbesen
OBJECTIVE: To study if severe hyperbilirubinemia in infants with no or minor neurologic symptoms in the neonatal period affects children’s development at the age of 1 to 5 years.METHODS: Controlled descriptive follow-up study of a national cohort of Danish children. The exposed group consisted of all live-born infants in Denmark from 2004 to 2007 with a gestational age ≥35 weeks and severe hyperbilirubinemia in the neonatal period, defined as at least 1 measure of total serum bilirubin level ≥25 mg/dL during the first 3 weeks of life. The exposed group of 206 children was matched with a control group of 208 children. The Ages and Stages Questionnaire (ASQ), a method of evaluating the child’s development, was filled in by parents. Main outcome measure was effect size of ASQ total score. Statistical analyses comprised a matched analysis of 102 pairs and a nonmatched regression analysis of all participants.RESULTS: The response rate was 79% (n = 162 of 206) in the study group and 70% (n = 146 of 208) in the control group. Neither the matched nor the nonmatched analysis showed any statistically significant differences between the groups; the effect size of the total score was 0.04 (−0.24 to 0.32) and −0.04 (−0.26 to 0.19), respectively.CONCLUSIONS: Using the parent-completed ASQ, we found no evidence of developmental delay in children aged between 1 and 5 years with severe neonatal hyperbilirubinemia compared with a matched control group.

18 January 2011 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
RMRené Mathiasen
René Mathiasen
BHBo Mølholm Hansen
Bo Mølholm Hansen
JFJulie Forman
Julie Forman
LKLars Vedel Kessing
Lars Vedel Kessing
GGGorm Greisen
Gorm Greisen

17 May 2022 in Acta Paediatrica
Verified
Journal Article
Closed access
BHBo Mølholm Hansen
Bo Mølholm Hansen
HCHeidi Cueto
Heidi Cueto
JPJesper Padkaer Petersen
Jesper Padkaer Petersen
GZGitte Zachariassen
Gitte Zachariassen
PCPia Sønderby Christensen
Pia Sønderby Christensen
THTine Brink Henriksen
Tine Brink Henriksen